An Integrative Multiomics Framework for Identification of Therapeutic Targets in Pulmonary Fibrosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
An Integrative Multiomics Framework for Identification of Therapeutic Targets in Pulmonary Fibrosis ; day:10 ; month:04 ; year:2023 ; extent:20
Advanced science ; (10.04.2023) (gesamt 20)
- Urheber
-
Arif, Muhammad
Basu, Abhishek
Wolf, Kaelin M.
Park, Joshua K.
Pommerolle, Lenny
Behee, Madeline
Gochuico, Bernadette R.
Cinar, Resat
- DOI
-
10.1002/advs.202207454
- URN
-
urn:nbn:de:101:1-2023041115045129600066
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Arif, Muhammad
- Basu, Abhishek
- Wolf, Kaelin M.
- Park, Joshua K.
- Pommerolle, Lenny
- Behee, Madeline
- Gochuico, Bernadette R.
- Cinar, Resat
Ähnliche Objekte (12)
Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression
Prioritization of therapeutic targets for cancers using integrative multi-omics analysis
Considerations for therapeutic intervention models of pulmonary fibrosis
Therapeutic targeting of 15-PGDH in murine pulmonary fibrosis
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Pulmonary hypertension in idiopathic pulmonary fibrosis
ANGPTL4 mediated mesothelial-mesenchymal transition in pulmonary fibrosis: a potential therapeutic target
Integrative analysis of lung molecular signatures reveals key drivers of idiopathic pulmonary fibrosis
Integrative Multi-omics Analysis of Childhood Aggressive Behavior
Integrative multi‐omics analysis of intestinal organoid differentiation
Nuclear MIRLET7D-induced inhibition of EP300 as therapeutic approach for idiopathic pulmonary fibrosis
Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression
Prioritization of therapeutic targets for cancers using integrative multi-omics analysis
Considerations for therapeutic intervention models of pulmonary fibrosis
Therapeutic targeting of 15-PGDH in murine pulmonary fibrosis
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Pulmonary hypertension in idiopathic pulmonary fibrosis
ANGPTL4 mediated mesothelial-mesenchymal transition in pulmonary fibrosis: a potential therapeutic target
Integrative analysis of lung molecular signatures reveals key drivers of idiopathic pulmonary fibrosis
Integrative Multi-omics Analysis of Childhood Aggressive Behavior
Integrative multi‐omics analysis of intestinal organoid differentiation
Nuclear MIRLET7D-induced inhibition of EP300 as therapeutic approach for idiopathic pulmonary fibrosis
Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression
Prioritization of therapeutic targets for cancers using integrative multi-omics analysis
Considerations for therapeutic intervention models of pulmonary fibrosis
Therapeutic targeting of 15-PGDH in murine pulmonary fibrosis
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Pulmonary hypertension in idiopathic pulmonary fibrosis
ANGPTL4 mediated mesothelial-mesenchymal transition in pulmonary fibrosis: a potential therapeutic target
Integrative analysis of lung molecular signatures reveals key drivers of idiopathic pulmonary fibrosis
Integrative Multi-omics Analysis of Childhood Aggressive Behavior
Integrative multi‐omics analysis of intestinal organoid differentiation